In nearly 20 years, aside from cholinesterase inhibitors, memantine is the only drug approved for the treatment of Alzheimer's disease (AD). Memantine is an uncompetitive N-methyl-D-aspartate ...

Nystagmus is characterized by involuntary to and fro movement of the eyes. There is evidence to indicate that memantine and gabapentin can reduce acquired nystagmus, but these drugs have not been ...